A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample.
Acta neuropsychiatrica April 25, 2024 Karl Sandström, Olli Kampman, Peter Asellus 1 citation
In a retrospective review of 46 patients who received intravenous ketamine for psychiatric treatment between 2015 and 2018, no significant difference was found in the number or duration of hospital admissions before versus after treatment. The response rate was 31% and the remission rate 21%. Although intravenous ketamine reduced depressive symptoms in complex patients in a real-world clinical setting, this did not lead to fewer hospitalizations, underscoring the multifaceted challenges of implementing this treatment in practice.